查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930040

抗生素市场规模、占有率、成长及全球产业分析：按类型、应用和地区划分的洞察与预测（2025-2034）

Antibiotics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 186 Pages | 商品交期: 请询问到货日

价格

抗生素市场成长驱动因子

全球抗生素市场在现代医疗保健中发挥着至关重要的作用，用于治疗影响全球数百万患者的各种细菌感染。抗生素常用于治疗呼吸道感染、泌尿道感染、皮肤感染、胃肠道感染、败血症和其他严重疾病。儘管人们对抗菌素抗药性 (AMR) 的担忧日益加剧，但抗生素仍然至关重要，从而推动了持续的市场需求。

市场规模与预测

根据 Fortune Business Insights 的数据，2025 年全球抗生素市值为 431.7 亿美元。预计到 2026 年，市场规模将成长至 448.4 亿美元，到 2034 年将达到 643.8 亿美元，在预测期（2026-2034 年）内，复合年增长率 (CAGR) 为 4.40%。

北美地区在 2025 年占市场主导地位，市场占有率为 45.44%，这得益于其先进的医疗保健基础设施、较高的处方率以及大型製药公司的强大影响力。

市场驱动因素

抗生素市场的主要驱动因素之一是全球细菌感染的日益普遍。结核病、肺炎、泌尿道感染、手术部位感染和血流感染等疾病的持续增加，使得对有效抗菌疗法的需求不断增长。

例如，根据世界卫生组织发布的 "2024年全球结核病报告" ，2023年全球约有1,080万人感染结核病。此外，医疗相关感染（HAI）仍然是一个重大问题，全球每十名患者中就有一名受到影响，尤其是在中低收入国家。这些因素显着推动了抗生素的消费和市场成长。

另一个主要驱动因素是研发活动的增加，特别着重于利用新型和联合抗菌疗法来应对抗药性感染。

市场限制因子

儘管需求强劲，但由于旨在遏制抗生素滥用和过度使用的严格法规，市场仍面临一些限制因素。各国政府和卫生部门正在积极实施抗菌药物管理计划，以对抗抗菌素抗药性 (AMR)。

根据医学期刊 "刺胳针" 发表的数据，2021 年有 114 万人死于抗生素抗药性，如果目前的趋势持续下去，预计到 2050 年，每年因抗生素抗药性导致的死亡人数将高达 1000 万人。此外，预计到 2050 年，因抗菌素抗药性造成的医疗保健成本将增加 1 兆美元，这将进一步加重医疗保健系统的负担，并限制抗生素的使用。

市场机会

抗生素抗药性感染的增加为开发新型和先进的抗生素疗法提供了巨大的机会。製药公司越来越关注联合用药和下一代抗生素。

例如，2025 年 2 月，艾伯维 (AbbVie) 的 EMBLAVEO（氨曲南和阿维巴坦）获得 FDA 批准，用于治疗复杂性腹腔内感染。此类核准可望开拓新的收入来源，并增强未来市场成长。

市场趋势

影响抗生素市场的关键趋势是全球抗菌药物管理计划 (ASP) 的普及。这些计划旨在促进合理使用抗生素，减少抗药性细菌，并改善治疗效果。

2024 年 3 月，ASPIRE 计画在非洲启动，旨在透过数位化创新、教育和政策干预来改善抗生素的使用。此类计划正在重新定义全球抗生素处方实践。

依细分市场分析

  • 依药物类别：

预计到 2026 年，青霉素类药物将占市场主导地位，市场占有率将达到 28.59%，这主要得益于其价格优势和仿製药的兴起。由于监管部门的批准和广谱抗菌活性，头孢菌素类药物预计将以更高的复合年增长率成长。

  • 依应用领域划分：

受肺炎和其他呼吸系统疾病在全球范围内的高发生影响，呼吸道感染领域预计到 2026 年将占市场主导地位，市场占有率达 23.75%。

  • 依给药途径划分：

预计到 2026 年，肠外抗生素将占 58.08% 的市场占有率，这主要得益于其对严重感染和医院获得性感染的有效性。

  • 依分销管道划分：

预计到 2026 年，医院药局将占领先地位，市占率达 60.71%，而线上药局预计将拥有最快的成长速度。

区域展望

  • 北美：预计2025年市场规模为194.9亿美元，2026年为202.6亿美元。
  • 亚太地区：由于低成本仿製药的高消费量和供应充足，预计该地区将以最高的复合年增长率增长。
  • 欧洲：拥有强大的研发生态系统和对创新抗生素的监管支援。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键洞察

  • 主要公司产品线分析
  • 抗菌药物治疗指引概要
  • 世界卫生组织发布的重点病原体抗生素抗药性概要
  • 主要产业发展动态－併购、合作等
  • 新冠疫情对全球抗生素市场的影响

第五章：全球抗生素市场分析、洞察与预测 (2021-2034)

  • 按药物类别划分的市场分析、洞察与预测
    • 青霉素类
    • 头孢菌素类
    • 氨基糖苷类
    • 四环素类
    • 大环内酯类
    • 氟喹诺酮类
    • 磺胺类
    • 其他
  • 按应用划分的市场分析、洞察与预测
    • 皮肤感染
    • 呼吸道感染
    • 泌尿道感染
    • 败血症
    • 耳部感染
    • 胃肠道感染
    • 其他
  • 依给药途径划分的市场分析、洞察与预测给药途径
    • 口服
    • 肠外给药
    • 其他
  • 市场分析、洞察与预测 - 按销售管道划分
    • 医院药房
    • 零售药房
    • 线上药房
  • 市场分析、洞察与预测 - 按地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美抗生素市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲抗生素市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章 亚太地区抗生素市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲抗生素市场分析、洞察与预测（2021-2034）

  • 依国家/地区
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章：中东和非洲抗生素市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会 (GCC)
    • 南非
    • 中东和非洲其他地区

第十一章 竞争分析

  • 全球市占率分析（2025）
  • 公司简介
  • 葛兰素史克 (GSK plc)
  • 百时美施贵宝 (Bristol-Myers Squibb Company)
  • 山德士集团 (Sandoz Group AG)
  • 默克公司 (Merck & Co., Inc.)
  • 辉瑞公司 (Pfizer Inc.)
  • 强生服务公司 (Johnson & Johnson Services, Inc.)
  • 拜耳 (Bayer)股份公司
  • 艾伯维公司
  • 盐野木工业株式会社
  • 雅培
  • 安斯泰来药厂
Product Code: FBI104583

Growth Factors of antibiotics Market

The global antibiotics market plays a vital role in modern healthcare by treating a wide range of bacterial infections affecting millions of patients worldwide. Antibiotics are commonly used for respiratory infections, urinary tract infections (UTIs), skin infections, gastrointestinal infections, septicemia, and other serious conditions. Despite growing concerns around antimicrobial resistance (AMR), antibiotics remain essential, driving sustained market demand.

Market Size and Forecast

According to Fortune Business Insights, the global antibiotics market size was valued at USD 43.17 billion in 2025. The market is projected to grow to USD 44.84 billion in 2026 and further reach USD 64.38 billion by 2034, expanding at a CAGR of 4.40% during the forecast period (2026-2034).

North America dominated the market in 2025 with a 45.44% market share, supported by advanced healthcare infrastructure, high prescription rates, and strong presence of leading pharmaceutical companies.

Market Drivers

One of the primary drivers of the antibiotics market is the rising prevalence of bacterial infections globally. Conditions such as tuberculosis, pneumonia, UTIs, surgical site infections, and bloodstream infections continue to increase demand for effective antibacterial therapies.

For instance, as per the WHO Global Tuberculosis Report 2024, approximately 10.8 million people worldwide were affected by tuberculosis in 2023. Additionally, healthcare-associated infections (HAIs) remain a major concern, with 1 in 10 patients globally affected, particularly in low- and middle-income countries. These factors significantly propel antibiotic consumption and market growth.

Another major driver is the increase in research and development (R&D) activities, especially focused on addressing drug-resistant infections through novel and combination antibiotic therapies.

Market Restraints

Despite strong demand, the market faces restraints due to stringent regulations aimed at reducing antibiotic misuse and overuse. Governments and healthcare authorities are actively implementing antimicrobial stewardship programs to combat AMR.

Data published in The Lancet highlights that antimicrobial resistance directly caused 1.14 million deaths in 2021, with projections estimating up to 10 million deaths annually by 2050 if current trends continue. Moreover, AMR is expected to add USD 1.0 trillion in healthcare costs by 2050, placing additional strain on healthcare systems and limiting antibiotic adoption.

Market Opportunities

The growing burden of antibiotic-resistant infections presents a significant opportunity for the development of novel and advanced antibiotic therapies. Pharmaceutical companies are increasingly focusing on combination drugs and next-generation antibiotics.

For example, in February 2025, AbbVie Inc. received FDA approval for EMBLAVEO (aztreonam and avibactam) for treating complicated intra-abdominal infections. Such approvals are expected to unlock new revenue streams and strengthen future market growth.

Market Trends

A key trend shaping the antibiotics market is the global adoption of Antimicrobial Stewardship Programs (ASPs). These initiatives aim to promote responsible antibiotic use, reduce resistance, and improve treatment outcomes.

In March 2024, the ASPIRE initiative launched in Africa to enhance antibiotic usage through digital innovation, education, and policy interventions. Such programs are redefining antibiotic prescribing practices worldwide.

Segmentation Insights

  • By Drug Class:

Penicillin dominated the market, accounting for 28.59% share in 2026, driven by affordability and increasing generic launches. Cephalosporins are expected to grow at a higher CAGR due to regulatory approvals and broad-spectrum efficacy.

  • By Application:

The respiratory infections segment led with a 23.75% share in 2026, supported by the high global burden of pneumonia and other respiratory diseases.

  • By Route of Administration:

Parenteral antibiotics held 58.08% market share in 2026, mainly due to their effectiveness in severe and hospital-acquired infections.

  • By Distribution Channel:

Hospital pharmacies dominated with 60.71% market share in 2026, while online pharmacies are projected to grow at the fastest rate.

Regional Outlook

  • North America: Market valued at USD 19.49 billion in 2025 and USD 20.26 billion in 2026.
  • Asia Pacific: Expected to grow at the highest CAGR due to high consumption and availability of low-cost generics.
  • Europe: Strong R&D ecosystem and regulatory support for innovative antibiotics.

Competitive Landscape

The market is semi-fragmented, with key players including Pfizer Inc., Sandoz Group AG, Astellas Pharma Inc., Merck & Co., GSK plc, and AbbVie Inc. These companies focus on generic expansion, R&D investment, acquisitions, and collaborations to strengthen global presence.

Conclusion

In conclusion, the global antibiotics market is set for steady growth from USD 43.17 billion in 2025 to USD 64.38 billion by 2034, despite regulatory challenges and antimicrobial resistance concerns. Rising bacterial infections, increased R&D investment, and the development of novel combination therapies continue to support market expansion. While antimicrobial stewardship programs may reduce misuse, they also promote sustainable and effective antibiotic utilization, ensuring long-term market stability and innovation-driven growth.

Segmentation Drug Class, Application, Route of Administration, Distribution Channel, and Region

By Drug Class * Penicillin

  • Cephalosporin
  • Aminoglycosides
  • Tetracycline
  • Macrolides
  • Fluoroquinolones
  • Sulfonamides
  • Others

By Application * Skin Infections

  • Respiratory Infections
  • Urinary Tract Infections
  • Septicemia
  • Ear Infection
  • Gastrointestinal Infections
  • Others

By Route of Administration * Oral

  • Parenteral
  • Others

By Distribution Channel * Hospital Pharmacy

  • Retail Pharmacy
  • Online Pharmacy

By Region * North America (By Drug Class, Application, Route of Administration, Distribution Channel, and Country)

    • U.S.
    • Canada
  • Europe (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Market Scope
  • 1.2. Market Segmentation
  • 1.3. Market Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Pipeline Analysis, By Key Players
  • 4.2. Overview of Antimicrobial Treatment Guidelines
  • 4.3. Overview of the Antibiotic resistant "Priority Pathogens" Published by WHO
  • 4.4. Key Industry Developments- Mergers, Acquisitions, Partnerships, etc.
  • 4.5. Impact of COVID 19 on Global Antibiotics Market

5. Global Antibiotics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Drug Class
    • 5.1.1. Penicillin
    • 5.1.2. Cephalosporin
    • 5.1.3. Aminoglycosides
    • 5.1.4. Tetracyclines
    • 5.1.5. Macrolides
    • 5.1.6. Fluoroquinolones
    • 5.1.7. Sulfonamides
    • 5.1.8. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Skin Infections
    • 5.2.2. Respiratory Infections
    • 5.2.3. Urinary Tract Infections
    • 5.2.4. Septicemia
    • 5.2.5. Ear Infection
    • 5.2.6. Gastrointestinal Infections
    • 5.2.7. Others
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Oral
    • 5.3.2. Parenteral
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Hospital Pharmacy
    • 5.4.2. Retail Pharmacy
    • 5.4.3. Online Pharmacy
  • 5.5. Market Analysis, Insights and Forecast - By Geography
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Antibiotics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Drug Class
    • 6.1.1. Penicillin
    • 6.1.2. Cephalosporin
    • 6.1.3. Aminoglycosides
    • 6.1.4. Tetracyclines
    • 6.1.5. Macrolides
    • 6.1.6. Fluoroquinolones
    • 6.1.7. Sulfonamides
    • 6.1.8. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Skin Infections
    • 6.2.2. Respiratory Infections
    • 6.2.3. Urinary Tract Infections
    • 6.2.4. Septicemia
    • 6.2.5. Ear Infection
    • 6.2.6. Gastrointestinal Infections
    • 6.2.7. Others
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Oral
    • 6.3.2. Parenteral
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Hospital Pharmacy
    • 6.4.2. Retail Pharmacy
    • 6.4.3. Online Pharmacy
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Antibiotics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Drug Class
    • 7.1.1. Penicillin
    • 7.1.2. Cephalosporin
    • 7.1.3. Aminoglycosides
    • 7.1.4. Tetracyclines
    • 7.1.5. Macrolides
    • 7.1.6. Fluoroquinolones
    • 7.1.7. Sulfonamides
    • 7.1.8. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Skin Infections
    • 7.2.2. Respiratory Infections
    • 7.2.3. Urinary Tract Infections
    • 7.2.4. Septicemia
    • 7.2.5. Ear Infection
    • 7.2.6. Gastrointestinal Infections
    • 7.2.7. Others
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Oral
    • 7.3.2. Parenteral
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Hospital Pharmacy
    • 7.4.2. Retail Pharmacy
    • 7.4.3. Online Pharmacy
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Antibiotics Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Drug Class
    • 8.1.1. Penicillin
    • 8.1.2. Cephalosporin
    • 8.1.3. Aminoglycosides
    • 8.1.4. Tetracyclines
    • 8.1.5. Macrolides
    • 8.1.6. Fluoroquinolones
    • 8.1.7. Sulfonamides
    • 8.1.8. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Skin Infections
    • 8.2.2. Respiratory Infections
    • 8.2.3. Urinary Tract Infections
    • 8.2.4. Septicemia
    • 8.2.5. Ear Infection
    • 8.2.6. Gastrointestinal Infections
    • 8.2.7. Others
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Oral
    • 8.3.2. Parenteral
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Hospital Pharmacy
    • 8.4.2. Retail Pharmacy
    • 8.4.3. Online Pharmacy
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Antibiotics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Drug Class
    • 9.1.1. Penicillin
    • 9.1.2. Cephalosporin
    • 9.1.3. Aminoglycosides
    • 9.1.4. Tetracyclines
    • 9.1.5. Macrolides
    • 9.1.6. Fluoroquinolones
    • 9.1.7. Sulfonamides
    • 9.1.8. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Skin Infections
    • 9.2.2. Respiratory Infections
    • 9.2.3. Urinary Tract Infections
    • 9.2.4. Septicemia
    • 9.2.5. Ear Infection
    • 9.2.6. Gastrointestinal Infections
    • 9.2.7. Others
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Oral
    • 9.3.2. Parenteral
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Hospital Pharmacy
    • 9.4.2. Retail Pharmacy
    • 9.4.3. Online Pharmacy
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Antibiotics Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Drug Class
    • 10.1.1. Penicillin
    • 10.1.2. Cephalosporin
    • 10.1.3. Aminoglycosides
    • 10.1.4. Tetracyclines
    • 10.1.5. Macrolides
    • 10.1.6. Fluoroquinolones
    • 10.1.7. Sulfonamides
    • 10.1.8. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Skin Infections
    • 10.2.2. Respiratory Infections
    • 10.2.3. Urinary Tract Infections
    • 10.2.4. Septicemia
    • 10.2.5. Ear Infection
    • 10.2.6. Gastrointestinal Infections
    • 10.2.7. Others
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Oral
    • 10.3.2. Parenteral
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Hospital Pharmacy
    • 10.4.2. Retail Pharmacy
    • 10.4.3. Online Pharmacy
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
    • 11.2.1. GSK plc
    • 11.2.2. Bristol-Myers Squibb Company
    • 11.2.3. Sandoz Group AG
    • 11.2.4. Merck & Co., Inc.
    • 11.2.5. Pfizer Inc.
    • 11.2.6. Johnson & Johnson Services, Inc.
    • 11.2.7. Bayer AG
    • 11.2.8. AbbVie Inc
    • 11.2.9. Shionogi & Co., Ltd.
    • 11.2.10. Abbott
    • 11.2.11. Astellas Pharma Inc.

List of Tables

  • Table 1: Global Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
  • Table 2: Global Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 4: Global Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 5: Global Antibiotics Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
  • Table 7: North America Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 8: North America Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 9: North America Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 10: North America Antibiotics Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
  • Table 12: Europe Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 13: Europe Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 14: Europe Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 15: Europe Antibiotics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
  • Table 17: Asia Pacific Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 18: Asia Pacific Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 19: Asia Pacific Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 20: Asia Pacific Antibiotics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
  • Table 22: Latin America Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Latin America Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 24: Latin America Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 25: Latin America Antibiotics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
  • Table 27: Middle East & Africa Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 28: Middle East & Africa Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 29: Middle East & Africa Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 30: Middle East & Africa Antibiotics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Antibiotics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Antibiotics Market Value Share (%), by Drug Class, 2025 & 2034
  • Figure 3: Global Antibiotics Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Antibiotics Market Value Share (%), by Route of Administration, 2025 & 2034
  • Figure 5: Global Antibiotics Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 6: Global Antibiotics Market Value Share (%), by Region, 2025 & 2034
  • Figure 7: North America Antibiotics Market Value (USD billion), by Drug Class, 2025 & 2034
  • Figure 8: North America Antibiotics Market Value Share (%), by Drug Class, 2025
  • Figure 9: North America Antibiotics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 10: North America Antibiotics Market Value Share (%), by Application, 2025
  • Figure 11: North America Antibiotics Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 12: North America Antibiotics Market Value Share (%), by Route of Administration, 2025
  • Figure 13: North America Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 14: North America Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 15: North America Antibiotics Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Antibiotics Market Value Share (%), By Country, 2025
  • Figure 17: Europe Antibiotics Market Value (USD billion), by Drug Class, 2025 & 2034
  • Figure 18: Europe Antibiotics Market Value Share (%), by Drug Class, 2025
  • Figure 19: Europe Antibiotics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 20: Europe Antibiotics Market Value Share (%), by Application, 2025
  • Figure 21: Europe Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 22: Europe Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 23: Europe Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 24: Europe Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 25: Europe Antibiotics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Antibiotics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Antibiotics Market Value (USD billion), by Drug Class, 2025 & 2034
  • Figure 28: Asia Pacific Antibiotics Market Value Share (%), by Drug Class, 2025
  • Figure 29: Asia Pacific Antibiotics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 30: Asia Pacific Antibiotics Market Value Share (%), by Application, 2025
  • Figure 31: Asia Pacific Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 32: Asia Pacific Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 33: Asia Pacific Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 34: Asia Pacific Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 35: Asia Pacific Antibiotics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Antibiotics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Antibiotics Market Value (USD billion), by Drug Class, 2025 & 2034
  • Figure 38: Latin America Antibiotics Market Value Share (%), by Drug Class, 2025
  • Figure 39: Latin America Antibiotics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 40: Latin America Antibiotics Market Value Share (%), by Application, 2025
  • Figure 41: Latin America Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 42: Latin America Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 43: Latin America Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 44: Latin America Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 45: Latin America Antibiotics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Antibiotics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Antibiotics Market Value (USD billion), by Drug Class, 2025 & 2034
  • Figure 48: Middle East & Africa Antibiotics Market Value Share (%), by Drug Class, 2025
  • Figure 49: Middle East & Africa Antibiotics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 50: Middle East & Africa Antibiotics Market Value Share (%), by Application, 2025
  • Figure 51: Middle East & Africa Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 52: Middle East & Africa Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 53: Middle East & Africa Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 54: Middle East & Africa Antibiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 55: Middle East & Africa Antibiotics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Antibiotics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Antibiotics Market Share (%), By Company, 2025